US12605288B2 - Ophthalmic Shield and Therapeutic Method
Summary
The USPTO granted Patent US12605288B2 to Ocular Surface Innovations Inc. for an ophthalmic shield and therapeutic method. The invention covers a method of obtaining eye metrics and determining manufacturing parameters for an ophthalmic shield with minimum dimensions ranging from 18mm × 15mm to 26mm × 22mm depending on embodiment. The patent contains 11 claims and names John Gelles and Jerome Legerton as inventors.
“A method is disclosed, comprising obtaining at least one metric of an eye; and determining, based on the at least one metric of the eye, at least one parameter for manufacturing an ophthalmic shield to be worn on the eye.”
About this source
USPTO classification A61F covers implanted devices, wound dressings, prosthetics, stents, orthopedic implants, heart valves, and external support devices for the human body. Every patent grant in A61F lands in this feed, around 220 a month, with the patent number, title, applicant, inventor names, and abstract. Watch this if you compete in medical devices, file freedom-to-operate analyses, scout acquisition targets in surgical implants or wound care, or follow which academic medical centers are commercializing research through patent filings. Recent grants cover infant umbilical cord stump protectors, absorbable wound dressings, and in-situ assembly prosthetic pacing valves.
What changed
The USPTO issued Patent US12605288B2 for an ophthalmic shield and therapeutic method to Ocular Surface Innovations Inc. The patent claims a method comprising obtaining at least one metric of an eye and determining manufacturing parameters for the ophthalmic shield based on those metrics. Different embodiments specify minimum horizontal dimensions of 18mm, 20mm, or 26mm with corresponding minimum vertical dimensions of 15mm, 17mm, or 22mm.
Affected parties include the patent holder (Ocular Surface Innovations Inc.) who now hold enforceable IP rights, and competitors in the ophthalmic device space who must respect the granted claims. The patent is a routine IP event that creates no compliance obligations but establishes enforceable exclusionary rights for the assignee.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Ophthalmic shield and therapeutic method
Grant US12605288B2 Kind: B2 Apr 21, 2026
Assignee
Ocular Surface Innovations Inc.
Inventors
John Gelles, Jerome Legerton
Abstract
A method is disclosed, comprising obtaining at least one metric of an eye; and determining, based on the at least one metric of the eye, at least one parameter for manufacturing an ophthalmic shield to be worn on the eye. In some embodiments, the ophthalmic shield may have a minimum horizontal dimension of 18 mm and a minimum vertical dimension of 15 mm. In some embodiments, the ophthalmic shield may have a minimum horizontal dimension of 20 mm and a minimum vertical dimension of 17 mm. In some embodiments, the ophthalmic shield may have a minimum horizontal dimension of 26 mm and a minimum vertical dimension of 22 mm.
CPC Classifications
A61F 7/03 A61F 9/0017 A61F 9/04 A61F 9/061 A61F 13/124 A61F 2007/0004 A61F 2007/0054 A61F 2007/0088
Filing Date
2021-12-10
Application No.
17547933
Claims
11
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Grants - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Prosthetics (A61F) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.